Evidence map›Paper›PMID 39310205›Full record

ArticleACS omega2024

An Orthogonal Workflow of Electrochemical, Computational, and Thermodynamic Methods Reveals Limitations of Using a Literature-Reported Insulin Binding Peptide in Biosensors.

Katherine Austin, Jazmine A Torres, Jeffery D V Waters, Eva Rose M Balog, Jeffrey M Halpern, Robert J Pantazes

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Katherine AustinDepartment of Chemical Engineering and Bioengineering, University of New Hampshire, Durham, New Hampshire 03824, United States.
Jazmine A TorresDepartment of Chemical Engineering, Auburn University, Auburn, Alabama 36849, United States.
Jeffery D V WatersSchool of Molecular and Physical Sciences, University of New England, Biddeford, Maine 04005, United States.ORCID https://orcid.org/0009-0009-9054-7846
Eva Rose M BalogSchool of Molecular and Physical Sciences, University of New England, Biddeford, Maine 04005, United States.ORCID https://orcid.org/0000-0001-6792-6914
Jeffrey M HalpernDepartment of Chemical Engineering and Bioengineering, University of New Hampshire, Durham, New Hampshire 03824, United States.ORCID https://orcid.org/0000-0003-0814-1986
Robert J PantazesDepartment of Chemical Engineering, Auburn University, Auburn, Alabama 36849, United States.ORCID https://orcid.org/0000-0002-0994-007X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing a continuous insulin-monitoring biosensor is of great importance for both the cellular biomanufacturing industry and for treating diabetes mellitus. Such a sensor needs to be able to effectively monitor insulin across a range of temperatures and pHs and with varying concentrations of competing analytes. One of the two main components of any biosensor is the recognition element, which is responsible for interacting with the molecule of interest. Prior literature describes an insulin-binding peptide (IBP) that was reported to bind to insulin with a 3 nM affinity. Here, we used orthogonal and complementary electrochemical, computational, and thermodynamic characterization methods to evaluate IBP's appropriateness for use in a biosensor. Unfortunately, all three methods failed to produce evidence of IBP-insulin binding either on surfaces or in solution. This indicates that the binding exhibited in previous reports is likely restricted to a limited set of conditions and that IBP is not a suitable recognition element for a continuous insulin biosensor.

Identifiers

PMID39310205
PMCPMC11411520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.